National and Kapodistrian University of Athens
Εκτίμηση του επιπέδου συγκέντρωσης των νεοπλασματικών δεικτών στη χολή και το παγκρεατικό υγρό στην πρώιμη διάγνωση των κακοήθων νεοπλασμάτων χοληφόρων και παγκρέατος
Abstract
dc:descriptionBackground: Our study aim was to establish cut-off levels and to report the usefulness of serum and bile Tumor Marker concentrations CEA, CA19-9, CA125, CA72-4 and CA242 in serum, bile and in pancreatic fluid, alone and in combined detection for discrimination of malignant from benign pancreatobiliary diseases. Methods: A total of ninety five (95) patients were enrolled in the study. The 1st group consisted of patients with malignant lesions (n=44) while the 2nd group consisted of patients with benign disease (n=51). ERCP was performed in all patients. Bile and pancreatic fluid was collected through an ERCP catheter. Serum samples were collected before ERCP, for measurement of total serum bilirubin and serum tumor markers CEA, CA19-9, CA125, CA242 and CA72-4. Results: Median serum total bilirubin, CEA, CA19-9, CA125 ,CA72-4 and CA242 along with median CA125 and CA72-4 measured in bile and median CEA and CA125 measured in pancreatic fluid were statistically significant higher in patients with malignant disease versus the benign disease group. Serum CA242 and CA19-9 exhibited the highest diagnostic accuracy (76,8% and 73,7%, respectively). Bile CA125 exhibited 69.5% diagnostic accuracy with CEA and CA72-4 having each 65.3%. CEA and CA125 measured in pancreatic fluid exhibited 86,2% and 69% diagnostic accuracy respectively.Combined detection, using any three of the five tumor markers (serum CA242, serum CA19-9, bile CA125, bile CA72-4 and total serum bilirubin), optimized results regarding sensitivity, specificity and diagnostic accuracy of 81,8%, 80,4% and 81,1% respectively. Conclusion: Serum, bile and pancreatic fluid tumor markers, when studied alone, lack the diagnostic yield to discriminate benign from malignant pancreatobiliary disease. In case of combined detection using any three of the five tumor markers (serum CA242, serum CA19-9, bile CA125, bile CA72-4 and total serum bilirubin), results are optimized within an acceptable range concerning sensitivity, specificity and diagnostic accuracy (81,8%, 80,4% and 81,1% respectively).
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Natsios, Athanasios
- Νάτσιος, Αθανάσιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/36491